The effect of green tea tablets in the treatment of polycystic ovary syndrome.
Not Applicable
- Conditions
- Polycystic ovarian syndrome.Stein-Leventhal syndrome
- Registration Number
- IRCT2015021816123N4
- Lead Sponsor
- Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
age 55-18, 40-25 Body Mass Index, a willingness to participate in the study,having two features of the following three characteristics: oligo ovulation or anovulation, clinical or biochemical evidence of hyperandrogenism,having more than 12 but less than 10 mm immature follicles in each ovary. Exclusion criteria: no appropriate corporation; any other disease, pregnancy and lactating
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;Insulin level. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;LDL. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;HDL. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;TG. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;Total Cholesterol. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;Hs-CRP. Timepoint: at the first and at the end of intervention period. Method of measurement: Elisa.;IL-6. Timepoint: at the first and at the end of intervention period. Method of measurement: Elisa.;TNF-a. Timepoint: at the first and at the end of intervention period. Method of measurement: Elisa.
- Secondary Outcome Measures
Name Time Method